Ozempic ‘microdosing’ is new weight-loss trend

Ozempic 3.0? This drug causes the greatest weight loss — by far
Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective for obese adults who do not have diabetes.
Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts weigh the pros and cons of the practice.
Should Medicaid Pay for Ozempic and Other Weight-Loss Drugs?
With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.
Ozempic and Wegovy have heart health benefits beyond just weight loss
A study in pigs has shown that the active ingredient in Ozempic and Wegovy directly boosts heart health, in addition to the benefits of losing weight
Could Trump Make A Big Weight Loss Drug Deal?
Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would drugmakers agree to reduce their prices right away?
As demand for weight-loss drugs rises, states grapple with Medicaid coverage
Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on Medicaid and have become yo-yo dieters who, despite their best efforts at changing their eating habits and lifestyles,
The Bulwark1h
Ozempic and Your Community
How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...
Ozempic vs. Wegovy: What’s the Difference?
Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?
West Virginia patients are left in limbo over changing insurance coverage of obesity medications
While West Virginia's employee health insurance program covers drugs like Ozempic for people with type 2 diabetes, officials ...
dailymemphian7d
‘It’s bonkers’ — how Ozempic, Wegovy change lives of those who struggle to lose weight
The medications are so common now, two-thirds of the clinic’s calls for insurance pre-authorizations are for the big three: ...
FiercePharma5d
Lilly’s Zepbound expected to surpass Novo’s Wegovy to ‘dominate’ obesity market: GlobalData
Lilly’s offering is expected to surpass Novo’s Wegovy in the space, and, according to a report this week from GlobalData, ...
Just-Food23h
GLP-1 drugs reduce US grocery spending by 6%, study claims
Users of GLP-1 drugs in the US cut their grocery spending by an average of 5.5% in the six months after taking the medication, a study shows.
BioSpace3dOpinion
Opinion: Why Is Novo Outperforming Lilly Despite Having Inferior GLP-1 Products?
Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are ...
FiercePharma21h
‘Ozempic’s biggest night’: GLP-1s back in Hollywood spotlight at Lilly-backed 2025 Golden Globes
Comedian Nikki Glaser, host of the 2025 Golden Globe Awards ceremony, dove right in at the start of her opening monologue: ...